embecta
Embecta Corp. is a medical device company based in Parsippany, New Jersey, specializing in diabetes care products. Founded in 1924, Embecta emerged from BD's diabetes business and now operates as an independent entity. The company manufactures a range of devices, including pen needles, syringes, and safety devices, all designed to enhance the administration of insulin and other diabetes treatments. In addition to its physical products, Embecta offers a digital application that supports patient management and therapy adherence. The company's offerings prioritize safety, comfort, and ease of use for individuals with diabetes, healthcare providers, and caregivers. Embecta is committed to improving patient outcomes and safety in insulin administration through its innovative medical devices and digital tools.
Work at embecta in HR or recruiting? Claim this page
Headcount trend
embecta went from 606 employees in Jul 2023 to 553 in Jun 2025. Jan to Jun 2025: 19 people joined, 59 left.
Headcount data through Jun 2025
Org structure
Headcount by department
Hiring now
See all jobsH-1B sponsorship
The department split adds up all the years listed above. FY2026 alone: 2 filings.
Peer reviews
Worked with someone at embecta?
Anonymous peer reviews on OffTheRecord
Similar companies
embecta FAQ
How many employees does embecta have?
embecta has about 553 employees, down 1.4% over the 3 months to Jun 2025.
Does embecta sponsor H1B visas?
Yes. embecta filed 2 H1B (LCA) applications in FY2026, according to the latest U.S. Department of Labor disclosures. Most of them were for Engineering roles.
What is embecta's revenue per employee?
embecta makes about $1.95M in revenue per employee, based on $1.08B annual revenue and 553 employees.
Is embecta a public company?
Yes. embecta is publicly traded under the ticker EMBC on NASDAQ.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.